10,188
Total Claims
$1.1M
Drug Cost
584
Beneficiaries
$1,945
Cost/Patient
Peer Comparison vs. 106,889 Family Practice providers
-38%
Opioid rate vs peers
1.6% vs 2.6% avg
+82%
Cost per patient vs peers
$1,945 vs $1,068 avg
+44%
Brand preference vs peers
13.0% vs 9.0% avg
Opioid Prescribing
1.6%
Opioid Rate
163
Opioid Claims
$1,165
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
87% generic
Brand: 1,309 claims · $941K
Generic: 8,789 claims · $191K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Empagliflozin | 138 | $148K |
| Semaglutide | 108 | $147K |
| Sitagliptin Phosphate | 89 | $76K |
| Dulaglutide | 42 | $60K |
| Apixaban | 43 | $45K |
| Semaglutide | 23 | $35K |
| Rivaroxaban | 28 | $30K |
| Mirabegron | 48 | $29K |
| Emtricitabine/Tenofov Alafenam | 12 | $28K |
| Insulin Glargine,hum.Rec.Anlog | 18 | $25K |
| Linagliptin | 32 | $22K |
| Fluticasone/Vilanterol | 47 | $22K |
| Tirzepatide | 15 | $21K |
| Sitagliptin Phos/Metformin Hcl | 19 | $21K |
| Sacubitril/Valsartan | 27 | $19K |
Prescribing Profile
Patient Profile
73
Avg Age
56%
Female
1.29
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About